Literature DB >> 7690156

Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase.

G Karupiah1, Q W Xie, R M Buller, C Nathan, C Duarte, J D MacMicking.   

Abstract

Interferons (IFNs) induce antiviral activity in many cell types. The ability of IFN-gamma to inhibit replication of ectromelia, vaccinia, and herpes simplex-1 viruses in mouse macrophages correlated with the cells' production of nitric oxide (NO). Viral replication was restored in IFN-gamma-treated macrophages exposed to inhibitors of NO synthase. Conversely, epithelial cells with no detectable NO synthesis restricted viral replication when transfected with a complementary DNA encoding inducible NO synthase or treated with organic compounds that generate NO. In mice, an inhibitor of NO synthase converted resolving ectromelia virus infection into fulminant mousepox. Thus, induction of NO synthase can be necessary and sufficient for a substantial antiviral effect of IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690156     DOI: 10.1126/science.7690156

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  237 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

Review 2.  On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies.

Authors:  Carolina Muscoli; Salvatore Cuzzocrea; Dennis P Riley; Jay L Zweier; Christoph Thiemermann; Zhi-Qiang Wang; Daniela Salvemini
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

3.  DISTINCT MECHANISMS OF INHIBITION OF VSV REPLICATION IN NEURONS MEDIATED BY TYPE I AND TYPE II IFN.

Authors:  Paul M D'Agostino; Jingjun Yang; Carol Shoshkes Reiss
Journal:  Virus Rev Res       Date:  2009-01-01

4.  Herpes simplex virus type 1 encephalitis is associated with elevated levels of F2-isoprostanes and F4-neuroprostanes.

Authors:  Dejan Milatovic; Yueli Zhang; Sandra J Olson; Kathleen S Montine; L Jackson Roberts; Jason D Morrow; Thomas J Montine; Terence S Dermody; Tibor Valyi-Nagy
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

5.  Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo.

Authors:  K Akarid; M Sinet; B Desforges; M A Gougerot-Pocidalo
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  Protective effect of exogenous recombinant mouse interferon-gamma and tumour necrosis factor-alpha on ectromelia virus infection in susceptible BALB/c mice.

Authors:  A V Atrasheuskaya; E K Bukin; T M Fredeking; G M Ignatyev
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

7.  Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa.

Authors:  D Gosselin; J DeSanctis; M Boulé; E Skamene; C Matouk; D Radzioch
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha.

Authors:  J P Maciejewski; C Selleri; T Sato; H J Cho; L K Keefer; C F Nathan; N S Young
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

9.  Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity.

Authors:  Z Bi; M Barna; T Komatsu; C S Reiss
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure.

Authors:  M C Subauste; D B Jacoby; S M Richards; D Proud
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.